Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2003
10/30/2003US20030204071 109 human secreted proteins
10/30/2003US20030204069 Segments of the human gene for telomerase reverse transcriptase
10/30/2003US20030204066 Using to anticytokine to treat rheumatic diseases; immunotherapy; immunoassay
10/30/2003US20030204065 Comprises peptidoglycan recognition protein (PGRP) for diagnosis and treatment of blood and tumor disorders
10/30/2003US20030204063 Growth hormone releasing factor; somatostatins; glucagon-like peptides; adrenocorticotropic hormones; atriopeptins; vasoactive intestinal peptides; for glucose intolerance associated with insulin resistance
10/30/2003US20030204060 Prepared by fermenting, incubating and eluting by washing with buffer, then chromatographing concentrated medium with lipophilic immobile phase comprising carrier coupled to 2-mercapto/hydroxyalkanoic acid
10/30/2003US20030204059 Preparing cytotoxic lymphocyte maturation factor (CLMF) from genetically engineered lymphoblastoid cells; for treating and preventing tumors and inflammation
10/30/2003US20030204058 Dendritic enriched secreted lymphocyte activation molecule
10/30/2003US20030204057 Chemically modified G-CSF
10/30/2003US20030204055 Comprise nucleotide sequences coding polypeptide for treating and preventing inflammation, tumors and nervous system disorders; animal models; gene therapy
10/30/2003US20030204054 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030204053 Comprise nucleotide sequences coding polypeptide for treating and preventing inflammation, tumors and nervous system disorders; animal models; gene therapy
10/30/2003US20030204052 Comprises polypeptide for treatment and prevention of autoimmune, cancer, inflammatory, nervous system, cardiomyopathy and atherosclerotic disorders
10/30/2003US20030204051 Contacting a sample with an aggregating amyloid A beta peptide to which is covalently bonded a fluorescent label and detecting the fluorescent label in association with such sample as an indication of an amyloid aggregate
10/30/2003US20030204049 Which have affinity/targeting vector for integrin receptors; diagnostic imaging
10/30/2003US20030204037 Methods for producing, films comprising, and methods for using heterogeneous crosslinked protein networks
10/30/2003US20030203976 Anti-angiogenic compositions and methods of use
10/30/2003US20030203869 Expression vectors for stimulating an immune response and methods of using the same
10/30/2003US20030203867 NIP3 family of proteins
10/30/2003US20030203866 Olfactory g-protein coupled coupled receptors; blot analysis; polymerase chain reactions; animal models
10/30/2003US20030203865 Lipid-comprising drug delivery complexes and methods for their production
10/30/2003US20030203864 Treatment of cancer
10/30/2003US20030203863 Interleukins (IL-2); cytokines; bovine growth hormone; cytomegalovirus; gene therapy
10/30/2003US20030203861 Nucleic acid vector containing a non-coding, immunostimulatory polynucleotide, comprised of six nucleotides arranged in the sequence 5'-purine-purine-unmethylated CpG-pyrimidine-pyrimidine-3'
10/30/2003US20030203848 Peptaibol antibiotics, synthesized from Acremonium tubakii, during fermentation and released into culture medium, containing high content of beta-aminobutyric acid and isovaline
10/30/2003US20030203843 Nucleic acids encoding cytoplasmic, nuclear, membrane bound, and secreted polypeptides (NOVX nucleic acids, NOVX polypeptides)
10/30/2003US20030203842 Apolipoprotein A-l agonists and their use to treat dyslipidemic disorders
10/30/2003US20030203841 T20/DP178 and T21/DP107 are activators of human phagocyte formyl peptide receptors
10/30/2003US20030203840 Nucleic acid containing at least one adenine base, a guanine base, a cytosine base, and at least thymin or uracil base and nucleic acid is atleast 12 bases in length, hybridizes to sense or antisense strand of second nucleic acid
10/30/2003US20030203471 Bacterial small-molecule three-hybrid system
10/30/2003US20030203469 Efficient purification of adenovirus
10/30/2003US20030203464 Comprise Gtpase (RAC-GEF) polypeptide for treating diagnosis and treatment of cell proliferative disorders; antiproliferative agents
10/30/2003US20030203462 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203452 Human chemokine beta-13
10/30/2003US20030203451 Interleukin-17 (IL-17)/G-protein coupled receptors protein for use in diagnosis and treatment of cell proliferative, bone and inflammatory disorders
10/30/2003US20030203450 STRL33, a human fusion accessory factor associated with HIV infection
10/30/2003US20030203446 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203445 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203444 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203443 Nucleotide sequences coding membrane protein for use as antiproliferative/antitumor/antiinflammatory/anticarcinogenic agents
10/30/2003US20030203442 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203441 Nucleotide sequences coding membrane protein for use as antiproliferative/antitumor/antiinflammatory/anticarcinogenic agents
10/30/2003US20030203440 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
10/30/2003US20030203439 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203438 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203437 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203436 Nucleotide sequences coding membrane protein for use as antiproliferative/antitumor/antiinflammatory/anticarcinogenic agents
10/30/2003US20030203435 Nucleotide sequences coding membrane protein for use as antiproliferative/antitumor/antiinflammatory/anticarcinogenic agents
10/30/2003US20030203434 Nucleotide sequences coding membrane protein for use as antiproliferative/antitumor/antiinflammatory/anticarcinogenic agents
10/30/2003US20030203433 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203432 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
10/30/2003US20030203431 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203430 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203429 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203428 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
10/30/2003US20030203426 Comprises proteins for diagnosis, treatment and prevention of arthritis, muscular, cancer, nervous system, sex and urogenital disorders
10/30/2003US20030203417 Yeast cells engineered to produce pheromone system protein surrogates and uses therefor
10/30/2003US20030203415 Comprises polypeptide for, diagnosis, detection and treatment of cancer
10/30/2003US20030203410 Gestational agents which modulate cell proliferation
10/30/2003US20030203409 Comprises monoclonal antibody for detection, diagnosis and treatment of cell proliferation disorders
10/30/2003US20030203402 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203401 Comprises nucleotide sequences coding membrane protein for diagnosing, preventing and treating cell proliferative, inflammatory or tumor disorders
10/30/2003US20030203383 Novel neurotrophic factor immunoassays
10/30/2003US20030203377 Complementary DNAs encoding proteins with signal peptides
10/30/2003US20030203375 Novel acidic mammalian proteins and polynucleotides encoding the same
10/30/2003US20030203373 Method for identifying a pharmacologically active substance
10/30/2003US20030203372 Analysis method
10/30/2003US20030203363 Novel human proteins, polynucleotides encoding them and methods of using the same
10/30/2003US20030203361 13 human colon and colon cancer associated proteins
10/30/2003US20030203359 Polyamide-oligonucleotide derivatives, their preparation and use
10/30/2003US20030203355 Preparing such binding ligands and libraries, and methods of identifying a binding ligand that specifically binds to a target molecule
10/30/2003US20030203350 Involves contacting the hemoglobin solution with a dissociating agent to form a dissociation solution wherein unmodified tetrameric hemoglobin is dissociated to form hemoglobin dimers which are separated from the solution
10/30/2003US20030203040 Controlled release microencapsulated NGF formulation
10/30/2003US20030203014 Positioning solid support into injury; wound healing agents; peptide
10/30/2003US20030203008 Papain digestion, phosphorylation
10/30/2003US20030202991 Delivery of biologically active polypeptides
10/30/2003US20030202989 Use of toxin peptides and/or affinity handles for delivering compounds into cells
10/30/2003US20030202988 Attenuated mutant; induce immunology response
10/30/2003US20030202987 Hepatitis virus; oligomer protein
10/30/2003US20030202985 Methods and compositions for immunotherapy of cancer
10/30/2003US20030202983 Protein for medical diagnosis; preventing infections; genetic engineering
10/30/2003US20030202982 Genetic engineering
10/30/2003US20030202980 Methods and reagents for decreasing clinical reaction to allergy
10/30/2003US20030202976 Methods and reagents for diagnosis and treatment of diabetes
10/30/2003US20030202971 Genetic engineering; binding polypeptide to antibody ; screening, modulation, calibration
10/30/2003US20030202967 Diabetic therapy
10/30/2003US20030202966 Isolated stromal cells and methods of using the same
10/30/2003US20030202962 Antigen encoded nucleic acids; controlling cell differentiation, cell proliferation; transcription factor controller
10/30/2003US20030202938 Hematopoietic growth factor inducible neurokinin-1 gene
10/30/2003CA2492655A1 Peptides capable of inducing attraction to the axonal growth and their use for treating neurodegenerative diseases
10/30/2003CA2483476A1 Fusion polypeptides and methods for inhibiting microbial adhesion
10/30/2003CA2483474A1 Lewis y epitope modified polypeptide, or mucin fusion polypetide, tumor vaccines
10/30/2003CA2483473A1 Mucin fusion polypeptide vaccines, compositions and methods of use thereof
10/30/2003CA2483343A1 Soluble mic polypeptides as markers for diagnosis, prognosis and treatment of cancer and autoimmune diseases or conditions
10/30/2003CA2483330A1 Multimeric ligands with enhanced stability
10/30/2003CA2483327A1 Oligonucleotides from coding sequences for the surface component of ptlvenvelope proteins and uses thereof
10/30/2003CA2483227A1 Antiviral inhibition of capsid proteins
10/30/2003CA2483144A1 Translocation dependent complementation for drug screening
10/30/2003CA2482995A1 Low-cost production of peptides
10/30/2003CA2482909A1 Tocopherol associated protein and uses thereof
1 ... 1501 1502 1503 1504 1505 1506 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 ... 2916